Shi-Ping Chen

759 total citations
14 papers, 645 citations indexed

About

Shi-Ping Chen is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Shi-Ping Chen has authored 14 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Shi-Ping Chen's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Shi-Ping Chen is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Shi-Ping Chen collaborates with scholars based in China, United States and France. Shi-Ping Chen's co-authors include Yong-Qiang Li, Jian‐Chuan Xia, Qi-Jing Wang, Li-Xi Huang, Jia He, De-Sheng Weng, Miao-La Ke, Ke Pan, Jing-Jing Zhao and Yi-Xin Zeng and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Shi-Ping Chen

14 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shi-Ping Chen China	12	392	377	156	126	59	14	645
Li-Xi Huang China	12	429 1.1×	349 0.9×	195 1.3×	150 1.2×	41 0.7×	13	691
Suzanne Fioravanti United States	12	452 1.2×	261 0.7×	146 0.9×	68 0.5×	71 1.2×	28	696
Rachel Swart United States	9	353 0.9×	202 0.5×	191 1.2×	194 1.5×	101 1.7×	11	671
Yong-Qiang Li China	17	677 1.7×	670 1.8×	271 1.7×	153 1.2×	106 1.8×	25	1.1k
Zhengguang Wang China	7	567 1.4×	665 1.8×	141 0.9×	49 0.4×	75 1.3×	18	935
Anna Spille Germany	6	504 1.3×	436 1.2×	64 0.4×	47 0.4×	48 0.8×	6	660
Yoon Lee South Korea	10	252 0.6×	398 1.1×	126 0.8×	30 0.2×	32 0.5×	13	573
Christian Quack Germany	3	359 0.9×	497 1.3×	86 0.6×	27 0.2×	26 0.4×	7	636
Yugang Wu China	14	286 0.7×	238 0.6×	113 0.7×	43 0.3×	72 1.2×	28	497
Kazuhiko Okada Japan	9	226 0.6×	251 0.7×	103 0.7×	42 0.3×	29 0.5×	30	496

Countries citing papers authored by Shi-Ping Chen

Since Specialization

Citations

This map shows the geographic impact of Shi-Ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi-Ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi-Ping Chen more than expected).

Fields of papers citing papers by Shi-Ping Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi-Ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi-Ping Chen. The network helps show where Shi-Ping Chen may publish in the future.

Co-authorship network of co-authors of Shi-Ping Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shi-Ping Chen. A scholar is included among the top collaborators of Shi-Ping Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi-Ping Chen. Shi-Ping Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pan, Qiu-Zhong, Qing Liu, Jing-Jing Zhao, et al.. (2020). CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma. Cancer Immunology Immunotherapy. 69(5). 825–834. 15 indexed citations

Zhou, Tie, Shuxiong Zeng, Qiang Wei, et al.. (2015). A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer. PLoS ONE. 10(1). e0117002–e0117002. 16 indexed citations

Pan, Qiu-Zhong, Qi-Jing Wang, Ke Pan, et al.. (2015). A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma. Scientific Reports. 5(1). 9202–9202. 23 indexed citations

Pan, Ke, Yong-Qiang Li, Jing-Jing Zhao, et al.. (2014). Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer. Clinical Cancer Research. 20(11). 3003–3011. 77 indexed citations

Pan, Ke, Yong-Qiang Li, Li Xu, et al.. (2013). The Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Therapy for Postoperative Hepatocellular Carcinoma Patients. Annals of Surgical Oncology. 20(13). 4305–4311. 68 indexed citations

Zhang, Lin, Gang Ma, Shi-Ping Chen, et al.. (2013). The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma. Journal of Translational Medicine. 11(1). 40 indexed citations

Chen, Yi-bing, Ke Pan, Wei Wang, et al.. (2012). Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer. PLoS ONE. 7(7). e40364–e40364. 91 indexed citations

Kita, K, et al.. (2012). Involvement of heat shock protein 27 in the susceptibility of KT human breast cancer cells to UVC and interferon lethality. Experimental and Therapeutic Medicine. 4(5). 913–917. 4 indexed citations

Xia, Jian‐Chuan, Ke Pan, Wei Wang, et al.. (2011). Intratumoral Expression of IL-17 and Its Prognostic Role in Gastric Adenocarcinoma Patients. International Journal of Biological Sciences. 7(1). 53–60. 90 indexed citations

10.

Wang, Wei, Lin Lv, Ke Pan, et al.. (2011). Reduced Expression of Transcription Factor AP-2α Is Associated with Gastric Adenocarcinoma Prognosis. PLoS ONE. 6(9). e24897–e24897. 36 indexed citations

11.

Wang, Qi-Jing, Hui Wang, Ke Pan, et al.. (2010). Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK. Chinese Journal of Cancer. 29(7). 641–648. 31 indexed citations

12.

Weng, De-Sheng, Jun Zhou, Ming Zhao, et al.. (2008). Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas. Journal of Immunotherapy. 31(1). 63–71. 127 indexed citations

13.

Mai, Shi-Juan, Tadamasa Ooka, Mu‐Sheng Zeng, et al.. (2007). Functional advantage of NPC-related V-val subtype of Epstein-Barr virus nuclear antigen 1 compared with prototype in epithelial cell line. Oncology Reports. 21 indexed citations

14.

Xia, Jian-chuan, De-Sheng Weng, Hai-De Qin, et al.. (2006). Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31. Cancer Genetics and Cytogenetics. 166(2). 166–172. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact